Concepedia

Stefanie Lindemann

SL

5

Publications

794

Citations

5

H-Index

2008

Active since

Affiliations

Bayer (Germany)(Current)

Bayer (United States)

Stefanie Lindemann is an author at Bayer (Germany) specializing in neurodegenerative diseases, biomedical imaging, and molecular imaging.

Top concepts

Publications per year

2008–2022

5

Publications

5

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Christopher C. Rowe, Uwe Ackerman, William F. Browne et al. · The Lancet Neurology · 2008 · 664 citations

, , +10

Radiation Dosimetry of β-Amyloid Tracers <sup>11</sup>C-PiB and <sup>18</sup>F-BAY94-9172

Graeme O’Keefe, Timothy Saunder, Steven Ng et al. · Journal of Nuclear Medicine · 2009 · 77 citations · Full text

CKD Prevalence Among Patients With and Without Type 2 Diabetes: Regional Differences in the United States

Xue Feng, Ryan Farej, Bonnie B. Dean et al. · Kidney Medicine · 2021 · 30 citations · Full text

Assessment of QT<sub>c</sub>‐prolonging potential of BX471 in healthy volunteers. A ‘thorough QT<sub>c</sub> study’ following ICH E14 using various QT correction methods

Marc Vandemeulebroecke, Jürgen Lembcke, Herbert Wiesinger et al. · British Journal of Clinical Pharmacology · 2009 · 12 citations · Full text

Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database

Christoph Wanner, Johannes Schuchhardt, Chris Bauer et al. · Journal of Nephrology · 2022 · 11 citations · Full text

Rows per page

1–5 of 5